Nucleoside antibiotics: biosynthesis, regulation, and biotechnology
G Niu, H Tan - Trends in microbiology, 2015 - cell.com
The alarming rise in antibiotic-resistant pathogens has coincided with a decline in the supply
of new antibiotics. It is therefore of great importance to find and create new antibiotics …
of new antibiotics. It is therefore of great importance to find and create new antibiotics …
Advances in biocatalytic and chemoenzymatic synthesis of nucleoside analogues
SC Cosgrove, GJ Miller - Expert Opinion on Drug Discovery, 2022 - Taylor & Francis
Introduction Nucleoside analogues represent a cornerstone of achievement in drug
discovery, rising to prominence particularly in the fields of antiviral and anticancer discovery …
discovery, rising to prominence particularly in the fields of antiviral and anticancer discovery …
Natural and engineered biosynthesis of nucleoside antibiotics in Actinomycetes
Nucleoside antibiotics constitute an important family of microbial natural products bearing
diverse bioactivities and unusual structural features. Their biosynthetic logics are unique …
diverse bioactivities and unusual structural features. Their biosynthetic logics are unique …
Recent advances in the biosynthesis of nucleoside antibiotics
T Shiraishi, T Kuzuyama - The Journal of Antibiotics, 2019 - nature.com
Nucleoside antibiotics are a diverse class of natural products with promising biomedical
activities. These compounds contain a saccharide core and a nucleobase. Despite the large …
activities. These compounds contain a saccharide core and a nucleobase. Despite the large …
Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics
S Rachakonda, L Cartee - Current Medicinal Chemistry, 2004 - ingentaconnect.com
Antimicrobial resistance in hospital and community settings is growing at an alarming rate
and has been attributed to such organisms as methicillin-resistant staphylococcus aureus …
and has been attributed to such organisms as methicillin-resistant staphylococcus aureus …
Nature's combinatorial biosynthesis and recently engineered production of nucleoside antibiotics in Streptomyces
S Chen, WA Kinney, S Van Lanen - World Journal of Microbiology and …, 2017 - Springer
Modified nucleosides produced by Streptomyces and related actinomycetes are widely used
in agriculture and medicine as antibacterial, antifungal, anticancer and antiviral agents …
in agriculture and medicine as antibacterial, antifungal, anticancer and antiviral agents …
Synthesis of complex nucleoside antibiotics
S Knapp - Chemical reviews, 1995 - ACS Publications
Complex nucleoside antibiotics comprise an extensive array of naturalproducts notable for
combining the structural features of nucleosides, higher monosac-charides, disaccharides …
combining the structural features of nucleosides, higher monosac-charides, disaccharides …
Nucleoside antibiotics: structure, biological activity, and biosynthesis
K Isono - The Journal of antibiotics, 1988 - jstage.jst.go.jp
This classification is conventional; someof the antibiotics possess structural features
covering more than two groups in the above classification. For example, liposidomycin B …
covering more than two groups in the above classification. For example, liposidomycin B …
Nucleoside derived antibiotics to fight microbial drug resistance: new utilities for an established class of drugs?
M Serpi, V Ferrari, F Pertusati - Journal of medicinal chemistry, 2016 - ACS Publications
Novel antibiotics are urgently needed to combat the rise of infections due to drug-resistant
microorganisms. Numerous natural nucleosides and their synthetically modified analogues …
microorganisms. Numerous natural nucleosides and their synthetically modified analogues …
Antimicrobial nucleoside antibiotics targeting cell wall assembly: Recent advances in structure–function studies and nucleoside biosynthesis
Covering: 2003 to 2009 The quest for new antibiotics, especially those with activity against
Gram-negative bacteria, is urgent; however, very few new antibiotics have been marketed in …
Gram-negative bacteria, is urgent; however, very few new antibiotics have been marketed in …